Centerline Biomedical

Centerline Biomedical, Inc. is revolutionizing interventional navigation with its innovative Intra-Operative Positioning System (IOPS™). The company's 3D vascular navigation system aims to enhance surgical precision and control, ultimately improving outcomes, reducing costs, and minimizing radiation exposure for patients and healthcare providers in minimally invasive endovascular procedures. Founded in 2014 as a spinoff of the renowned Cleveland Clinic, the company has garnered significant attention and support, including a recent $33.00M Series B investment from notable entities such as JobsOhio, GE Healthcare, Jumpstart Ventures, and G2 Venture Partners, among others. The innovative technology developed by Centerline Biomedical addresses the critical limitations of current x-ray fluoroscopy navigation, offering manipulable 3D models of anatomy without the drawbacks of excessive radiation exposure. This solution aligns with the growing preference for minimally invasive endovascular procedures, presenting substantial market potential. Furthermore, with its origin in the esteemed Lerner Research Institute’s Heart and Vascular Institute, the IOPS™ platform holds promise for predictive modeling, clinical decision support, healthcare analytics, and surgical education and training. The company's commitment to enhancing healthcare delivery and patient outcomes positions it as a compelling investment opportunity in the biotechnology and healthcare industries.